共 10 条
[1]
Comparison of strategies using cefairome and caftazidime for empiric treatment of pneumonia in intensive care patients. Wolff W. Antimicrobial Agents and Chemotherapy . 1998
[2]
Confronting drug-resistant pneumococci. Austrian,R. Annals of Internal Medicine . 1994
[3]
Epidmiology and in vitro susceptibility of drug-resistant streptococcus pneumonia. Appelbaum,PC. Pediatric Infectious Disease . 1996
[4]
Cost-effectiveness comparison of cefepime and ceftazidime using decision analysis. Paladino JA. Pharmacoeconomics . 1994
[5]
Preventing pneumococcal bacteremia in patients at risk: results of a matched case-control study. Farr BM. Archives of Internal Medicine . 1995
[6]
Ceftazidime to cefepime formuary switch: Pharmacodynamic and pharmacoeconomic rationale. Owens RC,Ambrose PG,Quintiliani R,et al. Connecticut Medicine . 1997
[7]
Etiology of peneumonia sepsis and meningitis in young infants younger than three months of age in Ethiopia. Muhe L,Tilahum M,Lulseged S,et al. Pediatric Infectious Disease . 1999
[8]
Bacterial and viral etiology of severe infection in Childrenless than three months old in the highlands of papua New Guinea. Lehmann D,Michael A,Omena M,et al. Pediatric Infectious Disease . 1999
[9]
The relationship between pneumonia in early childhood and impaired lung function in late adult life. Shaheen SO,Barker DJD,Shiell AW,et al. American Journal of Respiratory and Critical Care Medicine . 1994
[10]
Effect of pneumonia and whooping cough in childhood on adult lung function. Johnston ZDA,Srrachan DP,Anderson HR. The New England Journal of Medicine . 1998